Diagnostic accuracy of nasopharyngeal swab, nasal swab and saliva swab samples for the detection of SARS-CoV-2 using RT-PCR. Issue 8 (3rd August 2021)

• Record Type: Journal Article
• Authors: Tsujimoto, Yoshie; Terada, Junko; Kimura, Moto; Moriya, Ataru; Motohashi, Ayano; Izumi, Shinyu; Kawajiri, Kazuki; Hakkaku, Kazuo; Morishita, Momoko; Saito, Susumu; Takumida, Hiroshi; Watanabe, Hiromu; Tsukada, Akinari; Morita, Chie; Yamaguchi, Yoh; Katsuno, Takashi; Kusaba, Yusaku; Sakamoto, Keita; Hashimoto, Masao; Suzuki, Manabu; Takasaki, Jin; Hojo, Masayuki; Miyoshi-Akiyama, Tohru; Sugiyama, Haruhito
• Is Part Of: Infectious diseases. Volume 53:Issue 8(2021)
• Page Start: 581
• Page End: 589
• Publication Date: 2021-08-03
• Subjects: COVID-19 diagnostic test -- nasopharyngeal swab -- nasal swab -- saliva; Communicable diseases -- Periodicals; Communicable Diseases -- Periodicals; Communicable diseases; Periodicals; 616.9
• DOI: 10.1080/23744235.2021.1903550
• Languages: English
• ISSNs: 2374-4235

Abstract

Abstract: Background: The current gold standard in coronavirus disease (COVID-19) diagnostics is the real-time reverse transcription–polymerase chain reaction (RT-PCR) assay for detecting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in nasopharyngeal swab (NPS) samples. Alternatively, nasal swab (NS) or saliva swab (SS) specimens are used, although available data on test accuracy are limited. We examined the diagnostic accuracy of NPS/NS/SS samples for this purpose. Methods: Ten patients were included after being tested positive for SARS-CoV-2 RT-PCR in NPS samples according to the National Institute of Infectious Disease guidelines. In comparison with this conventional diagnostic method, NPS/NS/SS samples were tested using the cobas 6800 systems RT-PCR device. To investigate the usefulness of the cobas method and the difference among sample types, the agreement and sensitivity were calculated. Five to six samples were collected over a total period of 5–6 d from each patient. Results: Fifty-seven sets of NPS/NS/SS samples were collected, of which 40 tested positive for COVID-19 by the conventional method. Overall, the concordance rates using the conventional method were 86.0%/70.2%/54.4% for NPS/NS/SS samples (cobas); however, for samples collected up to and including on Day 9 after disease onset (22 negative and one positive specimens), the corresponding rates were 95.7%/87.0%/65.2%. The overall sensitivity estimates were 100.0%/67.5%/37.5% for NPS/NS/SS samples (cobas). For samples up to 9 d after onset, the corresponding values were 100.0%/86.4%/63.6%. Conclusions: NS samples are more reliable than SS samples and can be an alternative to NPS samples. They can be a useful diagnostic method in the future.